Companies: 49,246 Total Market Cap: 132386205533959.40

The ACME Laboratories Ltd.

DSE-ACMELAB
Pharmaceutical Preparations
Rank #22921
Market Cap 119.46 M
Volume 75,084
Price 0.56
Change (%) 0.14%
Country or region Bangladesh Bangladesh

The ACME Laboratories Ltd.'s latest marketcap:

119.46 M

As of 05/20/2025, The ACME Laboratories Ltd.'s market capitalization has reached $119.46 M. According to our data, The ACME Laboratories Ltd. is the 22921th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 119.46 M
Revenue (ttm) 282.24 M
Net Income (ttm) 19.52 M
Shares Out 211.60 M
EPS (ttm) 0.09
Forward PE 0.00
Ex-Dividend Date 11/21/2024
Earnings Date 04/24/2025
Market Cap Chart
Data Updated: 05/20/2025

The ACME Laboratories Ltd.'s yearly market capitalization.

The ACME Laboratories Ltd. has seen its market value drop from 15.81 B BDT to 14.71 B BDT since 2020, representing a total decrease of 6.96% and an annual compound decline rate (CAGR) of 1.63%.
Date Market Cap(BDT) Change (%)
05/20/2025 14.71 B -7.99%
12/30/2024 15.89 B -11.65%
12/28/2023 17.99 B 0%
12/29/2022 17.99 B -1.73%
12/30/2021 18.30 B 15.8%
12/30/2020 15.81 B

Company Profile

About ACME Laboratories Ltd.

ACME Laboratories Ltd. is a leading pharmaceutical company based in Bangladesh, specializing in the manufacture, marketing, and distribution of generic pharmaceutical formulations. Established in 1954 and headquartered in Dhaka, the company serves both domestic and international markets.

Product Portfolio

ACME Laboratories offers a diverse range of pharmaceutical products across multiple therapeutic categories, including:

  • Allergic disorders, analgesics, and antifibrinolytics
  • Anti-infectives, antivirals, and cardiovascular treatments
  • Central nervous system (CNS) and diabetes medications
  • Eye care, gastrointestinal, and respiratory solutions
  • Hormones, steroids, and vitamins/minerals
  • Ayurvedic, herbal, and nutraceutical products

Dosage Forms

The company provides medications in various forms, catering to human, veterinary, and herbal needs:

  • Human Drugs: Tablets, capsules, syrups, creams, injections, inhalers, and more.
  • Veterinary Drugs: Bolus, liquids, injections, and water-soluble powders.
  • Herbal Products: Liquids, capsules, tablets, and ointments.

With a strong presence in Bangladesh and export operations, ACME Laboratories continues to expand its reach in the pharmaceutical industry.

Frequently Asked Questions

As of 05/20/2025, The ACME Laboratories Ltd. (including the parent company, if applicable) has an estimated market capitalization of $119.46 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

The ACME Laboratories Ltd. global market capitalization ranking is approximately 22921 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Bangladesh
Founded 1954
IPO Date n/a
Employees 9,301
CEO Mizanur Sinha
Sector
Industry Pharmaceutical Preparations
Address Court de la ACME
Dhaka, 1207
Bangladesh
Website https://www.acmeglobal.com
People Also Watch
Ipsen S.A.
138.21 0.14%
Krka, d. d.
209.75 0.14%
BUD-RICHTER
29.11 0.14%
Hugel
244.93 0.14%